生命早期的喘息轨迹与生命后期明显的喘转录组有关
Kieran J Phelan1, Krishna M Roskin2, Jeffrey W Burkle3
1Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Medical Scientist Training Program, University of Cincinnati College of Medicine, Cincinnati, Ohio.
The Journal of allergy and clinical immunology
|April 6, 2025
概括
早期儿童喘息的不同模式与晚年生活中不同的基因表达变化有关,影响喘的发展. 根据特定的喘息轨迹量身定制预防策略可能会改善结果.
科学领域:
- 儿科呼吸系统医学 儿科呼吸系统医学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 幼儿喘呈现出多样化的发育模式.
- 这些喘息轨迹与生命后期喘的发展有着不同的联系.
研究的目的:
- 研究早期喘息轨迹对晚年喘相关基因表达的影响.
- 为了识别与不同喘息模式相关的特定分子特征.
主要方法:
- 利用了儿童呼吸环境工作组的数据,包括来自7个出生队伍的鼻样本.
- 采用潜阶级分析来从纵向数据中定义早期喘息轨迹.
- 应用加权基因相关性网络分析,将基因表达模式与喘息轨迹和当前喘状态联系起来.
主要成果:
- 确定了四种不同的早期喘息模式:不常见,短暂,晚发,持久.
- 过渡性喘息与增强的抗病毒反应相关;晚发喘息与改变的胰岛素信号传递和葡萄糖代谢有关.
- 与2型炎症和上皮细胞发育途径相关的持续喘息;与当前喘有关的持续喘息中独特的基因表达涉及神经元和毛功能.
结论:
- 生命早期的喘息轨迹与生命后期特定的喘相关的转录组相关.
- 这些发现表明,针对不同喘息模式的个性化喘预防策略可能更有效.
相关概念视频
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:20Asthma: Pathogenesis and Management
263
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
263
01:24Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K
01:47Lung Capacity
48.2K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
48.2K
01:17Other Pulmonary Disorders
786
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
786